Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q9D4H1

Entry ID Method Resolution Chain Position Source
1HK6 NMR - A 5-97 PDB
AF-Q9D4H1-F1 Predicted AlphaFoldDB

39 variants for Q9D4H1

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389268335 78 T>S No EVA
rs232871090 103 Q>P No EVA
rs3389243604 152 L>I No EVA
rs3389277880 216 Q>* No EVA
rs3389283611 246 L>F No EVA
rs3389272079 252 T>S No EVA
rs3389206240 256 L>M No EVA
rs226138701 289 N>S No EVA
rs3389268334 332 I>N No EVA
rs3389283633 337 E>K No EVA
rs3389274295 384 L>H No EVA
rs3389274358 388 C>G No EVA
rs242162969 399 H>L No EVA
rs220977349 402 P>L No EVA
rs3389272109 403 H>N No EVA
rs3389274319 432 S>R No EVA
rs3389272068 478 L>P No EVA
rs3389287392 483 A>G No EVA
rs3404018327 505 M>L No EVA
rs3403792520 507 Q>L No EVA
rs3389268353 550 H>Y No EVA
rs3389272110 568 P>S No EVA
rs3389268352 573 Q>L No EVA
rs1131790323 592 Q>* No EVA
rs3389293132 646 F>V No EVA
rs3389283659 663 M>V No EVA
rs3389243613 676 K>E No EVA
rs3389243592 689 D>N No EVA
rs3389243573 707 S>* No EVA
rs3389276088 709 Q>E No EVA
rs3389250886 711 L>F No EVA
rs3389268378 717 N>Y No EVA
rs3389283614 727 L>I No EVA
rs3402612270 764 I>N No EVA
rs3404116816 789 C>Y No EVA
rs3404195464 792 P>A No EVA
rs3404022326 792 P>Q No EVA
rs3403579160 847 S>C No EVA
rs3403930781 848 R>* No EVA

No associated diseases with Q9D4H1

2 regional properties for Q9D4H1

Type Name Position InterPro Accession
domain IPT domain 8 - 90 IPR002909
domain Exocyst complex component EXOC2/Sec5, N-terminal domain 133 - 914 IPR039481

Functions

Description
EC Number
Subcellular Localization
  • Midbody, Midbody ring
  • Recruitment to the midbody does not require RALA, nor RALB
  • Colocalizes with CNTRL/centriolin at the midbody ring
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
exocyst A protein complex peripherally associated with the plasma membrane that determines where vesicles dock and fuse. At least eight complex components are conserved between yeast and mammals.
Flemming body A cell part that is the central region of the midbody characterized by a gap in alpha-tubulin staining. It is a dense structure of antiparallel microtubules from the central spindle in the middle of the intercellular bridge.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

3 GO annotations of molecular function

Name Definition
protein kinase binding Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
protein N-terminus binding Binding to a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
small GTPase binding Binding to a small monomeric GTPase.

9 GO annotations of biological process

Name Definition
exocytosis A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle. Exocytosis can occur either by full fusion, when the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism that involves the formation of a transient contact, a pore, between a granule (for exemple of chromaffin cells) and the plasma membrane. The latter process most of the time leads to only partial secretion of the granule content. Exocytosis begins with steps that prepare vesicles for fusion with the membrane (tethering and docking) and ends when molecules are secreted from the cell.
Golgi to plasma membrane transport The directed movement of substances from the Golgi to the plasma membrane in transport vesicles that move from the trans-Golgi network to the plasma membrane, where they fuse and release their contents by exocytosis.
membrane fission A process that is carried out at the cellular level which results in the separation of a single continuous membrane into two membranes.
mitotic cytokinesis A cell cycle process that results in the division of the cytoplasm of a cell after mitosis, resulting in the separation of the original cell into two daughter cells.
positive regulation of exocytosis Any process that activates or increases the frequency, rate or extent of exocytosis.
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
regulation of entry of bacterium into host cell Any process that modulates the frequency, rate or extent of entry of bacterium into host cell.
vesicle docking involved in exocytosis The initial attachment of a vesicle membrane to a target membrane, mediated by proteins protruding from the membrane of the vesicle and the target membrane, that contributes to exocytosis.
vesicle tethering involved in exocytosis The initial, indirect interaction between a secretory vesicle membrane and a site of exocytosis in the plasma membrane. This interaction is mediated by tethering factors (or complexes), which interact with both membranes. Interaction can occur via direct binding to membrane phospholipids or membrane proteins, or via binding to vesicle coat proteins. This process is distinct from and prior to docking and fusion.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q96KP1 EXOC2 Exocyst complex component 2 Homo sapiens (Human) PR
10 20 30 40 50 60
MSRSRQPPLV TGISPNEGIP WTKVTIRGEN LGTGPTDLIG LTICGHNCLL TAEWMSASKI
70 80 90 100 110 120
VCRVGQAKND KGDIIVTTKS GGKGTSTVSF KLLKPEKIGI LDQSAVWVDE MNYYDMRTDR
130 140 150 160 170 180
NKGIPPLSLR PANPLGIEIE KCKLPQKNLE VLFHGMSADF TSENFSAAWY LIENHSTTSF
190 200 210 220 230 240
EQLKMAVTNL KRQANKKSEG SLAYVKGGLS TFFEAQDALS AIHQKLEADG TEKVEGSMTQ
250 260 270 280 290 300
KLENVLNRAS NTADTLFQEV LGRKDKADST RNALNVLQRF KFLFNLPLNI KRNIQKGDYD
310 320 330 340 350 360
VVINDYEKAK SLFGKTEVQV FKKYYAEVEA GIEDLRELLL KKLLETPSTL HDQKRYIRYL
370 380 390 400 410 420
SDLHAPGDPA WQCIGAQHKW TLKLMQDCKE GHMKSLKGHP GPHSPMLDLD NDVRPSVLGH
430 440 450 460 470 480
LSQTASLKRG SSFQSGRDDT WRYKTPHRVA FVEKLTKLVL SQLPNFWKLW ISYVNGSLFS
490 500 510 520 530 540
ETAEKSGQSE RSKNVRQRQN DFKKMIQEVM HSLVKLIRGA LLPLSLREGD GRQYGGWEVQ
550 560 570 580 590 600
AELSGQWLAH VIQTIRLTYE SLTALEIPND MLQIIQDLIL DLRIRCIMVT LQHTAEEIKR
610 620 630 640 650 660
LAEKEDWVVD NEGLTSLPCQ FEQSIVHSLQ SLKGVVDCKP GEASVFQQPK TQEEVCQLCI
670 680 690 700 710 720
NIMQVFIYCL EQLSTKPDAD IDTTHLSVDV SSPDLFGSIH EDFSLTSEQR LLIVLSNCCY
730 740 750 760 770 780
LERHTFLNIA EHFEKHNFQG IEKITQVSMA SLKELDQRLF ENYIELKADP IVGSLEPGIY
790 800 810 820 830 840
AGYFDWKDCL PPAGVRNYLK EALVNIIAVH AEVFTISKEL VPRVLARVVE AVSEELSRLM
850 860 870 880 890 900
QCVSSFSRNG ALQARLEICA LRDTVAIYLT SESRSSFKQA LEALPQLASG ADKKSLEELL
910 920
NKFKSSMHLQ LTCFQAASPA VMKT